Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Perspective

Development of Non-Coding RNAs as Biomarkers in Tumors of Digestive System

Author(s): Zhihua Xu* and Qiaoming Zhi*

Volume 19, Issue 2, 2019

Page: [143 - 144] Pages: 2

DOI: 10.2174/187152061902190418104708

Next »
[1]
Hahne, J.C.; Valeri, N. Non-Coding RNAs and resistance to anticancer drugs in gastrointestinal tumors. Front. Oncol., 2018, 8, 226.
[2]
Geisler, S.; Coller, J. RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat. Rev. Mol. Cell Biol., 2013, 14(11), 699-712.
[3]
Kang, W.; Zheng, Q.; Lei, J.; Chen, C.; Yu, C. Prognostic value of long noncoding RNAs in patients with gastrointestinal cancer: a systematic review and meta-analysis. Dis. Markers, 2018, 5340894.
[4]
Chen, S.; Zhang, Y.; Wu, X.; Zhang, C.; Li, G. Diagnostic value of lncRNAs as biomarker in hepatocellular carcinoma: An updated meta-analysis. Can. J. Gastroenterol. Hepatol., 2018, 8410195.
[5]
Lin, M.T.; Song, H.J.; Ding, X.Y. Long non-coding RNAs involved in metastasis of gastric cancer. World J. Gastroenterol., 2018, 24(33), 3724-3737.
[6]
Xi, Y.; Formentini, A.; Chien, M.; Weir, D.B.; Russo, J.J.; Ju, J.; Kornmann, M.; Ju, J. Prognostic values of microRNAs in colorectal cancer. Biomark. Insights, 2006, 2, 113-121.
[7]
Hibner, G.; Kimsa-Furdzik, M.; Francuz, T. Relevance of microRNAs as potential diagnostic and prognostic markers in colorectal cancer. Int. J. Mol. Sci., 2018, 19(10), 2944.
[8]
Stojanovic, J.; Tognetto, A.; Tizinao, D.F.; Leoncini, E.; Posteraro, B.; Pastorino, R.; Boccia, S. MicroRNAs expression profiles as diagnostic biomarkers of gastric cancer: A systematic literature review. Biomarkers, 2019, 24, 110-119.
[9]
Slotwinski, R.; Lech, G.; Slotwinska, S.M. MicroRNAs in pancreatic cancer diagnosis and therapy. Cent. Eur. J. Immunol., 2018, 43(3), 314-324.
[10]
Li, P.; Chen, S.; Chen, H.; Mo, X.; Li, T.; Shao, Y.; Xiao, B.; Guo, J. Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clin. Chim. Acta, 2015, 444, 132-136.
[11]
Xu, H.; Wang, C.; Song, H.; Xu, Y.; Ji, G. RNA-Seq profiling of circular RNAs in human colorectal cancer liver metastasis and the potential biomarkers. Mol. Cancer, 2019, 18(1), 8.
[12]
Sheng, J.Q.; Liu, L.; Wang, M.R.; Li, P.Y. Circular RNAs in digestive system cancer: Potential biomarkers and therapeutic targets. Am. J. Cancer Res., 2018, 8(7), 1142-1156.
[13]
Diamantopoulos, M.A.; Tsiakanikas, P.; Scorilas, A. Non-coding RNAs: The riddle of the transcriptome and their perspectives in cancer. Ann. Transl. Med., 2018, 6(12), 241.
[14]
Cheng, J.; Guo, J.M.; Xiao, B.X.; Miao, Y.; Jiang, Z.; Zhou, H.; Li, Q.N. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin. Chim. Acta, 2011, 412(17-18), 1621-1625.
[15]
Weng, W.; Liu, N.; Toiyama, Y.; Kusunoki, M.; Nagasaka, T.; Fujiwara, T.; Wei, Q.; Qin, H.; Lin, H.; Ma, Y.; Goel, A. Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer. Mol. Cancer, 2018, 17(1), 16.

© 2024 Bentham Science Publishers | Privacy Policy